McGill researchers found lecanemab may be less effective in women, prompting calls for more personalized treatment and ...

The participants in the study were given an experimental drug that removes amyloid proteins in the brain, which have long ...

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

Fortunately, the S&P 500 recovered to new all-time highs by August 2020 and is now up about 150% from its COVID lows.

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

An appointment with Wendell Helveston, M.D., a neurologist in Hattiesburg, MS, led to a series of diagnostic tests, such as ...

The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight ...